12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Controlled Release of LL-37-Derived Synthetic Antimicrobial and Anti-Biofilm Peptides SAAP-145 and SAAP-276 Prevents Experimental Biomaterial-Associated Staphylococcus aureus Infection

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: not found
          • Article: not found

          Bacterial Biofilms: A Common Cause of Persistent Infections

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Persister cells and tolerance to antimicrobials.

            Bacterial populations produce persister cells that neither grow nor die in the presence of microbicidal antibiotics. Persisters are largely responsible for high levels of biofilm tolerance to antimicrobials, but virtually nothing was known about their biology. Tolerance of Escherichia coli to ampicillin and ofloxacin was tested at different growth stages to gain insight into the nature of persisters. The number of persisters did not change in lag or early exponential phase, and increased dramatically in mid-exponential phase. Similar dynamics were observed with Pseudomonas aeruginosa (ofloxacin) and Staphylococcus aureus (ciprofloxacin and penicillin). This shows that production of persisters depends on growth stage. Maintaining a culture of E. coli at early exponential phase by reinoculation eliminated persisters. This suggests that persisters are not at a particular stage in the cell cycle, neither are they defective cells nor cells created in response to antibiotics. Our data indicate that persisters are specialized survivor cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mode of action of membrane active antimicrobial peptides.

              Water-membrane soluble protein and peptide toxins are used in the defense and offense systems of all organisms, including plants and humans. A major group includes antimicrobial peptides, which serve as a nonspecific defense system that complements the highly specific cell-mediated immune response. The increasing resistance of bacteria to conventional antibiotics stimulated the isolation and characterization of many antimicrobial peptides for potential use as new target antibiotics. The finding of thousands of antimicrobial peptides with variable lengths and sequences, all of which are active at similar concentrations, suggests a general mechanism for killing bacteria rather than a specific mechanism that requires preferred active structures. Such a mechanism is in agreement with the "carpet model" that does not require any specific structure or sequence. It seems that when there is an appropriate balance between hydrophobicity and a net positive charge the peptides are active on bacteria. However, selective activity depends also on other parameters, such as the volume of the molecule, its structure, and its oligomeric state in solution and membranes. Further, although many studies support that bacterial membrane damage is a lethal event for bacteria, other studies point to a multihit mechanism in which the peptide binds to several targets in the cytoplasmic region of the bacteria.
                Bookmark

                Author and article information

                Journal
                Advanced Functional Materials
                Adv. Funct. Mater.
                Wiley
                1616301X
                May 2017
                May 2017
                April 05 2017
                : 27
                : 20
                : 1606623
                Affiliations
                [1 ]Department of Medical Microbiology; Center for Infection and Immunity Amsterdam (CINIMA); Academic Medical Center; University of Amsterdam; Meibergdreef 15 1105 AZ Amsterdam The Netherlands
                [2 ]Department of Infectious Diseases; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
                [3 ]Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Albinusdreef 2 2333 ZA Leiden The Netherlands
                [4 ]PolyPid Ltd; 18 Hasivim St. Petach-Tikva 4959376 Israel
                [5 ]Institute of Molecular Biosciences; Biophysics Division; University of Graz; NAWI Graz; Humboldtstrasse 50/III 8010 Graz Austria
                [6 ]BioTechMed-Graz; Humboldstrasse 50/III 8010 Graz Austria
                Article
                10.1002/adfm.201606623
                f0ae1619-661f-41ef-b487-83987ee080d9
                © 2017

                http://doi.wiley.com/10.1002/tdm_license_1

                http://onlinelibrary.wiley.com/termsAndConditions

                History

                Comments

                Comment on this article